Inventiva
Inventiva est une entreprise française biopharmaceutique dont le siège se situe à Daix. Elle développe deux candidats médicaments, lanifibranor et odiparcil, ainsi qu'un portefeuille de plusieurs programmes en stade préclinique.
Filings
100 filings
- Inventiva annonce la reprise des négociations de ses actions ordinaires sur Euronext ParisInside informationFrench
- Inventiva Reports 2026 First Quarter Financial Information¹Inside informationFR
- Inventiva to Present at 2026 Jefferies Global Healthcare ConferenceInside informationFR
- Inventiva to Present Abstracts at the EASL Congress 2026Inside informationFR
- Inventiva reports preliminary 2025¹ fiscal year financial resultsInside information
- Inventiva reports 2025 Third Quarter Financial Information¹Inside informationFR
- Inventiva announces launch of public offeringInside informationFR
- Inventiva Announces the Implementation of a New ATM ProgramInside informationFR
- Inventiva Appoints Andrew Obenshain as Chief Executive OfficerInside informationFR
- Inventiva to Host Analyst and Investor Event on October 8, 2025Inside informationFR
- Inventiva to Participate in Upcoming September Investor ConferencesInside informationFR
- Inventiva Reports Preliminary 2025 First-Half Financial Information¹Inside informationFR
- Inventiva receives $10 million milestone payment from CTTQInside informationFR
About
- ISIN
- FR0013233012
- Ticker
- IVA
- LEI
- 969500I9Y690B3FZW590
- Sector
- Health care
- Country of registration
- FR
- Last filing
- 30/07/2026, 22:00
Description from Wikidata, CC0 licence.
Filing history
Filings per month
26
Sept 23May 24Jan 25Sept 25Aug 26
Document types
Across the whole archive